SEC Filing Document

Company: BIOVENTRIX, INC.
Ticker: 
CIK: 1283259
Filing Type: S-1/A
Document Type: EX-10.7
Date Filed: 2026-03-18
Accession Number: 0001493152-26-010642
Exchange: 
SIC Code: 3841
SIC Description: Surgical & Medical Instruments & Apparatus
URL: https://www.sec.gov/Archives/edgar/data/1283259/000149315226010642/ex10-7.htm

Chunk 3 of 7
Word Count: 1459
Character Count: 9225

Document Content:

such manner as the Auditor shall determine. Not later than ten (10) days after such decision and in accordance with such decision, Licensee shall pay the additional amounts, with interest from the date originally due as provided in Section 3.2 or HFHS shall reimburse the excess payments, as applicable. 10. LIFE OF THE AGREEMENT 10.1 Unless otherwise terminated by operation of law, or by acts of the parties in accordance with the terms of this Agreement, this Agreement will remain in effect from the Effective Date until the expiration or abandonment of the last of the Patent Rights licensed hereunder. 10.2 Any termination or expiration of this Agreement will not affect the rights and obligations set forth in the following Articles, or in any Article which under its terms or by reasonable implication may be performed after termination or expiration of this Agreement: Article 1 Definitions Paragraph 3.7 Late Payments

Article
4	License
Fees

Article
5	Earned
Royalties

Article
9	Books
and Records

Article
10	Life
of the Agreement

Article
12	Disposition
of Licensed Products and Licensed Methods upon Termination or Expiration

Article
13	Use
of Names and Trademarks

Article
Warranty and Limitation of Liability

Article
15	Patent
Prosecution and Maintenance

Article
18	Indemnification
and Insurance

Article
19	Notices

Article
21	Waiver

Article
23	Governing
Laws; Venue

Article
26	Confidentiality

Article
27	Miscellaneous

Article
28	Taxes

Article
29	Electronic
Disposition

Article
Contest of Proprietary Rights

10.3 The
termination or expiration of this Agreement will not relieve the Licensee of its obligation to pay any fees, royalties or other payments
owed to HFHS at the time of such termination or expiration and will not impair any accrued right of HFHS, including the right to receive
Earned Royalties in accordance with Articles 5 (Earned Royalties) and 12 (Disposition of Licensed Products and Licensed Methods Upon
Termination or Expiration).

11. TERMINATION BY LICENSOR OR LICENSEE

Termination by HFHS. If the Licensee fails to perform or violates any term of this Agreement, then HFHS may give written notice of
such default (“Notice of Default”) to the Licensee. If the Licensee fails to repair such default within sixty (60)
days after the date of such notice, then HFHS will have the right to immediately terminate this Agreement and its licenses by
providing a written notice of termination (“Notice of Termination”) to the Licensee.

11.2 Termination
by Licensee. Licensee has the ability to terminate this License by a written Notice sent on a date subsequent to the third anniversary
of Effective Date, providing ninety (90) days’ notice of termination.

12. DISPOSITION OF LICENSED PRODUCTS AND LICENSED METHODS UPON TERMINATION OR EXPIRATION

12.1 Upon
termination (but not expiration) of this Agreement, within a period of one hundred and twenty (120) days after the date of termination,
the Licensee is entitled to dispose of all previously made or partially made Licensed Product or Licensed Method, but no more, provided
that the Sale or use of such Licensed Product or Licensed Method are made within one (1) year after the date of termination subject to
the terms of this Agreement, including, but not limited to, the rendering of reports and payment of Earned Royalties and any other payments
therefore required under this Agreement. The Licensee may not otherwise make, Sell, offer for Sale or import Licensed Products or practice
the Licensed Method after the date of termination.

applicable Patent Rights exist at the time of any making, Sale, offer for Sale, or import of a Licensed Product or Licensed Method or
the time of any Sale or offer for Sale, then Earned Royalties shall be paid at the times provided herein and royalty reports shall be
rendered in connection therewith, notwithstanding the absence of applicable Patent Rights with respect to such Licensed Product or Licensed
Method at any later time. Any fees or other payments owed to HFHS at the time of expiration not based on the Sales of a Licensed Product
or Licensed Method will be paid to HFHS at the time such fee or other payment would have been due had this Agreement not expired.

13. USE OF NAMES AND TRADEMARKS

Nothing
contained in this Agreement will be construed as conferring any right to either party to use in advertising, publicity or other promotional
activities any name, trade name, trademark or other designation of the other party (including a contraction, abbreviation or simulation
of any of the foregoing). Without either party’s consent, the Licensee may only list HFHS name as a licensor of technology and
HFHS may only list Licensee’s name as a licensee of technology from HFHS.

14. NO WARRANTY AND LIMITATION OF LIABILITY

14.1 PATENT
RIGHTS WERE PREVIOUSLY LICENSED TO SYMPHONY MEDICAL, INC. HFHS SENT NOTICE OF TERMINATION TO CARDIOPOLYMERS (WHICH HAD MADE AN ASSIGNMENT
FOR THE BENEFIT OF CREDITORS), LLC AND LONESTAR (WHICH HAD MADE AN ASSIGNMENT FOR THE BENEFIT OF CREDITORS), LLC (AS SUCCESSORS TO THE
THEN-CURRENT LICENSEE), AFTER THAT ENTITY HAD MADE AN ASSIGNMENT FOR THE BENEFIT OF CREDITORS FOR THE REASON THAT ASSIGNOR HAD BECOME
INSOLVENT AND APPOINTED ASSIGNEE TO LIQUIDATE THE ASSETS OF ASSIGNOR. HFHS DOES NOT REPRESENT THAT ANY FORMER LICENSEE OR AN ASSIGNEE
WILL NOT MAKE A CLAIM AS TO RIGHTS IN PATENT RIGHTS.

14.2 ALL
PATENT RIGHTS, INTELLECTUAL PROPERTY, INFORMATION, MATERIALS, SERVICES OR OTHER PROPERTY OR RIGHTS, LICENSED OR PROVIDED OR GENERATED
BY HFHS PURSUANT TO THIS AGREEMENT (“DELIVERABLES”) ARE PROVIDED ON AN “AS IS” BASIS. HFHS MAKES NO WARRANTIES
OF ANY KIND, EITHER EXPRESSED OR IMPLIED, AS TO ANY MATTER INCLUDING, BUT NOT LIMITED TO, WARRANTY OF FITNESS FOR PARTICULAR PURPOSE,
OR MERCHANTABILITY, EXCLUSIVITY OR RESULTS OBTAINED FROM USE. HFHS MAKES NO WARRANTY OF ANY KIND WITH RESPECT TO FREEDOM FROM PATENT,
TRADEMARK OR COPYRIGHT INFRINGEMENT OR THEFT OF TRADE SECRETS AND DOES NOT ASSUME ANY LIABILITY HEREUNDER FOR ANY INFRINGEMENT OF ANY
PATENT, TRADEMARK OR COPYRIGHT ARISING THEREFROM. THE PARTIES AGREE THAT THEY WILL NOT MAKE ANY WARRANTY ON BEHALF OF THE OTHER PARTY,
EXPRESSED OR IMPLIED, TO ANY ENTITY REGARDING PATENT RIGHTS, INCLUDING BUT NOT LIMITED TO CONCERNING THE APPLICATION OF OR THE RESULTS
TO BE OBTAINED DURING PERFORMANCE OF THIS AGREEMENT. NOTWITHSTANDING ANYTHING HEREIN TO THE CONTRARY, IN NO EVENT WILL EITHER PARTY BE
LIABLE TO THE OTHER FOR ANY SPECIAL, EXEMPLARY, INCIDENTIAL, INDIRECT, PUNITIVE, OR CONSEQUENTIAL DAMAGES (INCLUDING, BUT NOT LIMITED
TO, LOST PROFITS, INABILITY TO USE PATENT RIGHTS OR ANY APPLICATIONS AND DERIVATIVES THEREOF, REVENUE, AND BUSINESS), WHETHER BASED ON
BREACH OF CONTRACT, TORT (INCLUDING NEGLIGENCE), STATUTE, EQUITY, PRODUCT LIABILITY, BREACH, OR OTHERWISE ARISING OUT OF OR RELATED TO
THIS AGREEMENT, REGARDLESS OF WHETHER OR NOT THAT PARTY HAS BEEN ADVISED OF THE POSSIBILITY OF ANY SUCH DAMAGES.

14.3 FOR THE AVOIDANCE OF DOUBT, THIS AGREEMENT DOES NOT:

14.3.1	EXPRESS
OR IMPLY A WARRANTY OR REPRESENTATION AS TO THE VALIDITY, ENFORCEABILITY, OR SCOPE OF ANY PATENT RIGHTS; OR

14.3.2	EXPRESS
OR IMPLY A WARRANTY OR REPRESENTATION THAT ANYTHING MADE, USED, SOLD, OFFERED FOR SALE OR IMPORTED UNDER ANY LICENSE GRANTED IN THIS
AGREEMENT IS OR WILL BE FREE FROM INFRINGEMENT OF PATENTS, COPYRIGHTS, OR OTHER RIGHTS OF THIRD PARTIES; OR

14.3.3	OBLIGATE
HFHS TO BRING OR PROSECUTE ACTIONS OR SUITS AGAINST THIRD PARTIES FOR PATENT INFRINGEMENT; OR

14.3.4	CONFER
BY IMPLICATION, ESTOPPEL OR OTHERWISE ANY LICENSE OR RIGHTS UNDER ANY PATENTS OR PATENT APPLICATIONS OR OTHER RIGHTS OF HFHS OTHER THAN
PATENT RIGHTS, REGARDLESS OF WHETHER SUCH PATENTS ARE DOMINANT OR SUBORDINATE TO PATENT RIGHTS.

15. PATENT PROSECUTION AND MAINTENANCE

Licensee
will diligently prosecute and maintain the United States and foreign patents comprising the Patent Rights using counsel of its choice
and bear the costs of preparing, filing, prosecuting and maintaining all United States and foreign patent applications contemplated by
this Agreement (“Patent Prosecution Costs”). The Licensee shall use reasonable efforts to amend any patent application to
include claims reasonably requested by the other Party to protect the Products contemplated to be Sold, or the Licensed Method to be
practiced, under this Agreement. Licensee shall pay the attorneys’ fees and other costs incurred if those efforts were incurred
in the prosecution of the patents even if those efforts were incurred prior to the Effective Date but the bill therefor has not been
included in the calculation of the amount to be paid pursuant to Section 4.2 above.

16. PATENT MARKING

The
Licensee will mark all Licensed Products and Licensed Methods made, used or Sold under the terms of this Agreement or their containers
in accordance with the applicable patent marking laws.

17. PATENT INFRINGEMENT

the event that HFHS or the Licensee learns of infringement of potential commercial significance of any Patent Rights, the knowledgeable
party will provide the other (i) with written notice of such infringement and (ii) with any evidence of such infringement available to
it (the “Infringement Notice”).